Eversept Partners, LP - Q4 2018 holdings

$185 Million is the total value of Eversept Partners, LP's 54 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .

 Value Shares↓ Weighting
MYL NewMYLAN N Vcall$4,345,640158,600
+100.0%
2.35%
TSRO NewTESARO INC$2,673,00036,000
+100.0%
1.45%
FATE NewFATE THERAPEUTICS INC$2,116,950165,000
+100.0%
1.15%
QGEN NewQIAGEN NV$1,905,08555,300
+100.0%
1.03%
ILMN NewILLUMINA INC$1,544,0405,148
+100.0%
0.84%
GHDX NewGENOMIC HEALTH INC$1,537,20923,866
+100.0%
0.83%
MYL NewMYLAN N V$1,507,00055,000
+100.0%
0.82%
DCPH NewDECIPHERA PHARMACEUTICALS IN$1,463,00369,700
+100.0%
0.79%
LOXO NewLOXO ONCOLOGY INC$1,400,70010,000
+100.0%
0.76%
NTRA NewNATERA INC$551,96439,539
+100.0%
0.30%
FLDM NewFLUIDIGM CORP DEL$434,92250,455
+100.0%
0.24%
OPNT NewOPIANT PHARMACEUTICALS INC$200,86913,901
+100.0%
0.11%
AQXP NewAQUINOX PHARMACEUTICALS INC$159,22973,717
+100.0%
0.09%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2023-11-08
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMARIN CORP PLC21Q3 202312.5%
DANAHER CORPORATION21Q3 20238.1%
AFFIMED N V20Q3 20230.9%
ARGENX SE19Q3 20232.0%
GSK PLC18Q2 202213.1%
ASCENDIS PHARMA A/S18Q1 20227.7%
SANOFI18Q4 20227.2%
ENSIGN GROUP INC18Q1 20228.6%
CENTENE CORP DEL18Q3 20231.5%
ZOGENIX INC17Q4 202112.4%

View Eversept Partners, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Eversept Partners, LP Q4 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cabaletta Bio, Inc.February 14, 2023282,8741.0%
Teligent, Inc.Sold outFebruary 16, 202100.0%
Teligent, Inc.February 14, 20204,501,7998.4%

View Eversept Partners, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08
13F-HR/A2023-11-08

View Eversept Partners, LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Eversept Partners, LP's holdings